DrugPatentWatch Database Preview
Blue Earth Company Profile
» See Plans and Pricing
What is the competitive landscape for BLUE EARTH, and when can generic versions of BLUE EARTH drugs launch?
BLUE EARTH has one approved drug.
There are four US patents protecting BLUE EARTH drugs.
There are thirty-seven patent family members on BLUE EARTH drugs in sixteen countries.
Summary for Blue Earth
| International Patents: | 37 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Blue Earth
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 9,387,266 | Start Trial | Start Trial | ||||
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 5,808,146 | Start Trial | Y | Start Trial | |||
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | 10,124,079 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Blue Earth Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 101643991 | Start Trial |
| Japan | 5341136 | Start Trial |
| China | 101316812 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
